DHR - Danaher Corporation Stock Analysis

Stock Taper

OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS

DHR

DANAHER CORPORATION

NYSE

$203.30

▲ UP 1.58% (3.16)

KEY STATISTICS

Market Cap$140.64 B

52w High$242.80

52w Low$160.93

Dividend Yield0.74%

FrequencyQuarterly

P/E25.48

Volume3.42M

Shares Out.702.99M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Rainer Blair

COMPENSATION 2026

Salary$1,300,000

Stock Awards$8,068,474

Incentive Plan Pay$3,541,200

All Other Comp.$484,191

Total$20,903,282

ABOUT

SECTOR

Healthcare

WENT PUBLIC

December 29, 1978

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

59,000

PRICE TARGET

Target High$250.00

Target Low$195.00

Target Median$230.00

Target Consensus$223.77

UPCOMING EARNINGS

DateOct 20, 2026

DayTuesday

Rev. Est.$6.55B

OCT

TUE

SPLIT RECORD

DATE	TYPE	RATIO
2023-10-02	Forward	141:125
2016-07-05	Forward	1319:1000
2010-06-14	Forward	2:1
2004-05-21	Forward	2:1
1998-06-01	Forward	2:1
1995-01-23	Forward	2:1
1987-09-09	Forward	2:1

PRICE

$203.30 ▲ UP 1.58% (+$3.16)

OVERLAYS

About Danaher Corporation

https://www.danaher.com ↗

Danaher Corporation designs and markets global professional, medical, industrial, and environmental products across three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT DANAHER CORPORATION IS KNOWN FOR

ZenoTOF 8600 system

In June 2025, SCIEX launched a cutting-edge mass spectrometer delivering rapid, high-resolution, and highly sensitive analysis of complex biological samples for proteomics, metabolomics, and genomics applications.